AI-generated summary
The authors report a randomized controlled trial of dual-wavelength photobiomodulation added to a fibrin sponge after gingival graft donor site surgery in 30 patients. Overall wound closure, pain and analgesic use did not differ significantly, but the treated group showed more donor sites with complete epithelial coverage by day 10. The authors note the findings are preliminary and suggest an effect on early healing only.
- Participants
- 30
- Who or what was studied
- Patients undergoing de-epithelialized free gingival graft harvesting (palatal donor sites)
- Limits stated in the abstract
- The abstract reports only early-healing differences in epithelialization, with no significant effect on overall wound closure, pain, or analgesic use, and the authors frame the results as preliminary.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Wavelength, Photobiomodulation therapy, Photobiomodulation, Randomized controlled trial, Visual analogue scale, Trial registration, Wound healing. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.